This bibliometric analysis overviews the research status and development trends of engineered exosomes, revealing that new drug delivery platforms and immunological engineered exosomes are frontier focuses in the context of interdisciplinary collaboration.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: